Market Cap | ₹13,177Cr |
ROE | 13.50% |
P/E Ratio(TTM) | 27.48 |
EPS(TTM) | 19.76 |
P/B Ratio | 3.55 |
Dividend Yield | 0.28% |
Industry P/E | 35.77 |
Book Value | 153.11 |
Debt to Equity | 0.39 |
Face Value | 1 |
Parent Organisation | Granules India Limited |
Managing Director | Dr. Kandiraju Rao |
NSE Symbol | GRANULES |
FUND NAME | AUM(%) |
---|---|
Tata Mid Cap Direct Plan Growth | 1.00% |
Tata Large Cap Direct Plan Growth | 1.00% |
Axis Value Fund Direct Growth | 0.98% |
Edelweiss Balanced Advantage Fund Direct Growth | 0.85% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 104.06 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.19 | ||
Emcure Pharmaceuticals | NA (0.00%) | 34.19 | ||
Wockhardt | NA (0.00%) | -198.91 |